Longitudinal Cost of Septal Myectomy Versus Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.

[1]  B. Maron,et al.  Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy. , 2019, The American journal of cardiology.

[2]  S. Ommen,et al.  Determinants of Reverse Remodeling of the Left Atrium After Transaortic Myectomy. , 2018, The Annals of thoracic surgery.

[3]  E. Heist,et al.  Emergency Department Visits for Atrial Fibrillation in the United States: Trends in Admission Rates and Economic Burden From 2007 to 2014 , 2018, Journal of the American Heart Association.

[4]  B. Maron,et al.  Global Burden of Hypertrophic Cardiomyopathy. , 2018, JACC. Heart failure.

[5]  H. Schaff,et al.  Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation , 2017, Circulation research.

[6]  B. Maron,et al.  Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience. , 2017, Annals of cardiothoracic surgery.

[7]  N. Lakdawala,et al.  Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy. , 2016, Circulation.

[8]  H. Schaff,et al.  Septal myectomy for patients with hypertrophic cardiomyopathy: A new paradigm. , 2016, The Journal of thoracic and cardiovascular surgery.

[9]  N. Smedira,et al.  Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. , 2015, Journal of the American College of Cardiology.

[10]  S. Ommen,et al.  Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy? , 2015, The Journal of thoracic and cardiovascular surgery.

[11]  B. Maron,et al.  Surgical Septal Myectomy Versus Alcohol Septal Ablation: Assessing the Status of the Controversy in 2014 , 2014, Circulation.

[12]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[13]  Nilay D Shah,et al.  Optum Labs: building a novel node in the learning health care system. , 2014, Health affairs.

[14]  B. Gersh,et al.  Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population , 2014, Journal of the American Heart Association.

[15]  Kari Lock Morgan,et al.  Balancing Covariates via Propensity Score Weighting , 2014, 1609.07494.

[16]  B. Groves,et al.  Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. , 2011, Journal of the American College of Cardiology.

[17]  Y. Adler,et al.  COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. , 2010, European heart journal.

[18]  P. Serruys,et al.  Long-Term Outcome of Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy: A Word of Caution , 2010, Circulation. Heart failure.

[19]  I. Palacios,et al.  Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.

[20]  A. Tajik,et al.  Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. , 2007, European heart journal.

[21]  B. Maron.  Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy , 2007 .

[22]  A. Tajik,et al.  Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[23]  M. Link,et al.  Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2006, Circulation.

[24]  N. Lakkis,et al.  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. , 2006, Journal of interventional cardiology.

[25]  P. Boekstegers,et al.  Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. , 2005, Zeitschrift fur Kardiologie.

[26]  B. Gersh,et al.  Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[27]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.